FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suzanne Elliott

Research Profile

Anatomy

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Chemicals & Drugs

Concepts & Ideas

Molecular Sequence Data

Physiology

Disorders

Procedures

Vaccination

Co-author Network

Publications

TOP 3
Suzanne L Elliott; Andreas Suhrbier; John J Miles; Gregor Lawrence; SJ Pye; Thuy T T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis Moss; Mandvi Bharadwaj
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.
Joanne E Davis; Martina A Sherritt; Mandvi Bharadwaj; Leanne E Morrison; Suzanne L Elliott; Laurie M Kear; Joanne Maddicks-Law; Tom Kotsimbos; Devinder Gill; Monique Malouf; Michael C Falk; Rajiv Khanna; Denis Moss
Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.
Martina A Sherritt; Mandvi Bharadwaj; Jacqueline M Burrows; Leanne E Morrison; Suzanne L Elliott; Joanne E Davis; Laurie M Kear; Richard E Slaughter; Scott C Bell; Andrew J Galbraith; Rajiv Khanna; Denis Moss
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suzanne Elliott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Suzanne L Elliott; Andreas Suhrbier; John J Miles; Gregor Lawrence; SJ Pye; Thuy T T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis Moss; Mandvi Bharadwaj
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.
Journal of virology 2008;82(3):1448-57.
2004: Joanne E Davis; Martina A Sherritt; Mandvi Bharadwaj; Leanne E Morrison; Suzanne L Elliott; Laurie M Kear; Joanne Maddicks-Law; Tom Kotsimbos; Devinder Gill; Monique Malouf; Michael C Falk; Rajiv Khanna; Denis Moss
Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.
International immunology 2004;16(7):983-9.
2003: Martina A Sherritt; Mandvi Bharadwaj; Jacqueline M Burrows; Leanne E Morrison; Suzanne L Elliott; Joanne E Davis; Laurie M Kear; Richard E Slaughter; Scott C Bell; Andrew J Galbraith; Rajiv Khanna; Denis Moss
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.
Transplantation 2003;75(9):1556-60.
2003: Tonia Woodberry; Joy Gardner; Suzanne L Elliott; Sonja Leyrer; David M Purdie; Paul Chaplin; Andreas Suhrbier
Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2599-604.
2001: Sharon L Silins; Martina A Sherritt; J M Silleri; SM Cross; Suzanne L Elliott; Mandvi Bharadwaj; T T Le; Leanne E Morrison; Rajiv Khanna; Denis Moss; A Suhrbier; Ihor Misko
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.
Blood 2001;98(13):3739-44.
2000: Martina A Sherritt; Joy Gardner; Suzanne L Elliott; C Schmidt; David Purdie; Georgia Deliyannis; W R Heath; Andreas Suhrbier
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines.
European journal of immunology 2000;30(2):671-7.
1999: Luis Mateo; Joy Gardner; Qiyuan Chen; C Schmidt; M Down; Suzanne L Elliott; SJ Pye; Hueseyin Firat; François A Lemonnier; Jonathan Cebon; Andreas Suhrbier
An HLA-A2 polyepitope vaccine for melanoma immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(7):4058-63.
1999: Rajiv Khanna; S Bell; Martina A Sherritt; Andrew J Galbraith; Scott R Burrows; L Rafter; Belinda Clarke; R Slaughter; Michael C Falk; J Douglass; T Williams; Suzanne L Elliott; Denis Moss
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(18):10391-6.
1999: Denis Moss; Rajiv Khanna; Martina A Sherritt; Suzanne L Elliott; Scott R Burrows
Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies.
Journal of acquired immune deficiency syndromes (1999) 1999;21 Suppl 1():S80-3.
1999: Tonia Woodberry; Joy Gardner; Luis Mateo; D Eisen; Jill C Medveczky; Ian A Ramshaw; Scott A Thomson; Rosemary Ffrench; Suzanne L Elliott; Hueseyin Firat; François A Lemonnier; Andreas Suhrbier
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.
Journal of virology 1999;73(7):5320-5.
1999: Suzanne L Elliott; SJ Pye; T Le; Luis Mateo; J Cox; L Macdonald; Anthony A Scalzo; C A Forbes; Andreas Suhrbier
Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.
Vaccine 1999;17(15-16):2009-19.
1999: Ihor Misko; SM Cross; Rajiv Khanna; Suzanne L Elliott; C Schmidt; SJ Pye; Sharon L Silins
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2279-84.
1998: D J Moss; A Suhrbier; Suzanne L Elliott
Candidate vaccines for Epstein-Barr virus.
BMJ (Clinical research ed.) 1998;317(7156):423-4.
1998: Scott A Thomson; Martina A Sherritt; Jill C Medveczky; Suzanne L Elliott; Denis Moss; Germain Fernando; Lorena E Brown; Andreas Suhrbier
Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1717-23.
1997: Sharon L Silins; SM Cross; Suzanne L Elliott; SJ Pye; Jacqueline M Burrows; Denis Moss; Ihor Misko
Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
International immunology 1997;9(11):1745-55.
1997: Suzanne L Elliott; SJ Pye; C Schmidt; SM Cross; Sharon L Silins; Ihor Misko
Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
The Journal of infectious diseases 1997;176(4):1068-72.
1997: Scott R Burrows; Sharon L Silins; SM Cross; Chen Au Peh; M Rischmueller; Jacqueline M Burrows; Suzanne L Elliott; James McCluskey
Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.
European journal of immunology 1997;27(1):178-82.
1996: Sharon L Silins; SM Cross; Suzanne L Elliott; SJ Pye; Scott R Burrows; Jacqueline M Burrows; Denis Moss; V P Argaet; Ihor Misko
Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
The Journal of experimental medicine 1996;184(5):1815-24.
1996: Scott A Thomson; Suzanne L Elliott; Martina A Sherritt; K W Sproat; Barbara E H Coupar; Anthony A Scalzo; C A Forbes; A M Ladhams; X Y Mo; Ralph A Tripp; Peter C Doherty; Denis Moss; Andreas Suhrbier
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(2):822-6.
1995: Anthony A Scalzo; Suzanne L Elliott; J Cox; Joy Gardner; Denis Moss; Andreas Suhrbier
Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).
Journal of virology 1995;69(2):1306-9.